Bridgebio Pharma

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Biotech stocks and secondary and initial public offerings were well represented this week. A couple of chief executive officers also stepped up to the buy window last week. Conventional...

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not confirmed. Cambium Networks Corp (CMBM) will issue 5.8 million shares between $13 and $15 Wednesday on the Nasdaq. The offering represents 22.7% of outstanding shares and is...